Clinical Trials Browser

Recurrence × Microbiota × Clear all

NCT04636775 2023-12-11

Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

Carcinoma, Non-Small-Cell Lung, Recurrence